1 Min Read
April 13 (Reuters) - U.S. FDA:
* FDA ADVANCES POLICIES TO BRING GREATER PREDICTABILITY AND CERTAINTY TO THE DRUG DEVELOPMENT PROCESS
* U.S. FDA SAYS GUIDANCE ISSUED PROVIDES DETAILED OVERVIEW OF THE SPECIAL PROTOCOL ASSESSMENT (SPA) PROCESS